Biosimilar in lymphoma treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Κύριος συγγραφέας: | Tanisha, Mehrin Haque |
---|---|
Άλλοι συγγραφείς: | Kabir, Eva Rahman |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2021
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/15533 |
Παρόμοια τεκμήρια
-
CAR-T cell Therapy in B-cell Lymphoma
ανά: Faruk, Asef
Έκδοση: (2020) -
Targeted therapeutic options in the treatment of Breast Cancer
ανά: Alam, Kazi Tasnuva
Έκδοση: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
ανά: Tania, Umme
Έκδοση: (2023) -
Biologics and Biosimilars as Treatment Options for Psoriasis
ανά: Moya, Amena Khatun
Έκδοση: (2023) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
ανά: Tania, Umme
Έκδοση: (2021)